Frank Bringstrup

Frank Bringstrup has extensive work experience in the regulatory affairs field. Frank currently serves as the Vice President of Regulatory Affairs at Calliditas Therapeutics AB, a position they have held since February 2019. Prior to this, they worked at Novo Nordisk for over 17 years, holding various roles including Senior Global Regulatory Lead, Associate Regulatory Project Manager, Regulatory Professional, and Safety Surveillance Adviser. Frank also has experience as a Senior Management Consultant at Lisberg Management Consulting/Muusmann Research and Consulting A/S. Before entering the consulting industry, they worked as a Medical Adviser/Consultant at Frederiksborg County, Public Health Care Management. Frank'scareer started at the Danish National Board of Health as a Medical Adviser. Frank also has experience in clinical practice as a MD at Rigshospitalet/Bispebjerg Hospital/Frederiksberg Hospital in Copenhagen.

Frank Bringstrup received their MD degree from the University of Copenhagen (Københavns Universitet) between 1981 and 1990. In 2008, they obtained a Diploma in Business Administration and Management from the University of Warwick - Warwick Business School. Additionally, they received a Diploma in Managing Medical Product Innovation (MMPI) from Copenhagen Business School in 2015. Prior to their university education, Bringstrup attended Roskilde Handelsskole in 1980-1981, where they earned a Business High School degree.